University of Buffalo
>> Sunday, January 3, 2010
Researchers at the University of Buffalo are developing an asymmetric stent to act as a monotherapy flow diverting device to exculde aneurysms from circulation. The product is pre-clinical with promising results.
0 comments:
Post a Comment